the asymmetric synthesis of alkaloids.9 The utility of these
new building blocks is illustrated in concise four-step
enantioselective syntheses of (R)-(+)-2-phenylpiperidine (7)
and (-)-SS20846A (14).
To illustrate the utility of (+)-3, (R)-(+)-2-phenylpiperi-
dine (7) was prepared in four steps from (SS,R)-(+)-3
(Scheme 2). Removal of the N-sulfinyl in 3 with 5 equiv of
Earlier we reported that (S)-(+)-N-benzylidene-p-toluene-
sulfinamide (1) reacts with the sodium enolate of methyl
acetate in ether at -78 °C to give N-sulfinyl â-phenylalanine
2 in 84% yield and >97% de (Scheme 1).10 Subsequent
Scheme 2
Scheme 1
TFA in MeOH/CH2Cl2 gave the amine (not shown), which
was passed through a short pad of silica gel to remove methyl
p-toluenesulfinate, prior to reaction with saturated NaHCO3
in CH2Cl2 to give (R)-(+)-6-phenylpiperidine-2,4-dione (4)
as a solid in 90% yield.11 Dione 4 was treated with 10 equiv
of ethanedithiol and 2.5 equiv of BF3‚OEt2 at rt in CH2Cl2
for 8 h to give the thioketal (R)-(+)-5, which was isolated
in 85% yield by chromatography. Next, (+)-5 was subjected
to W2 Raney nickel desulfurization in EtOH to give (R)-
(+)-6-phenylpiperidin-2-one (6) in 75% isolated yield.
Reduction with LAH at rt for 8 h gave an 82% yield of the
volatile (R)-(+)-6-phenylpiperidine (7), which was purified
by chromatography.12 The enantiomeric purity was deter-
treatment of 2 with 4 equiv of the sodium enolate of methyl
acetate, prepared from NaHMDS and methyl acetate, affords
(SS,R)-(+)-methyl 3-oxo-N-(p-toluenesulfinyl)-5-amino-5-
phenylpentanoate (3) in 93% yield following flash chroma-
tography. The de was >97%. About 10-15% of â-keto ester
3 exists as the enol form in solution. Significantly, (+)-3
can be prepared in one step, in 89% yield, by treating the
sulfinimine 1 with 5 equiv of the enolate generated from 5
equiv of methyl acetate and 6 equiv of NaHMDS. The de
was the same, i.e., >97%. Although the one-step method is
more concise, the two-step procedure could be advantageous
if the initial enolate addition was not highly diastereoselec-
tive. In this case, up-grading the diastereomeric purity of
the â-amino ester could be performed prior to formation of
the δ-amino â-keto ester.
mined to be >98% ee by comparison of its rotation, [R]20
D
50.0 (c 0.31, CH2Cl2), with literature values, [R]23 48.4 (c
D
0.31, CH2Cl2), for 98% ee.12b
2-Substituted-4-piperidones represent an important class
of building blocks for the synthesis of substituted piperidine
derivatives13 and other biologically active materials.14 In this
context the application of δ-amino â-keto esters to the
synthesis of these chiral building blocks was demonstrated
in the asymmetric synthesis of (-)-(2S,4S)-SS20846 A (14).
SS20846 A (14) was isolated from Steptomyces sp. S2084615
and is a proposed intermediate in the biosynthesis of the
potent antimicrobial agent streptazolin.16 It is also reported
(9) For references to δ-amino â-keto esters, see: (a) Li, B.; Franck, R.
W. Bioorg. Med. Chem. Lett. 1999, 9, 2629. (b) Werner, R. M.; Shokek,
O. Davis, J. T. J. Org. Chem. 1997, 62, 8243.
(10) Davis, F. A.; Reddy, R. E.; Szewczyk, J. M. J. Org. Chem. 1995,
60, 7037.
(15) Komoto, T.; Yano, K.; Ono, J.; Okawa, J.; Nakajima, T. Jpn. Kokai
35788(20/02/1986); Chem. Abstr. 1986, 105, 132137w.
(16) (a) Mayer, M.; Thiericke, R. J. Org. Chem. 1993, 58, 3486. (b)
Grabley, S.; Hammann, P.; Kluge, H.; Wink, J.; Kricke, P.; Zeeck, A. J.
Antibiot. 1991, 44, 797.
(17) Davis, F. A.; Zhang, Y. Andemichael, Y.; Fang, T.; Fanelli, D. L.;
Zhang, H. J. Org. Chem. 1999, 64, 1043.
(11) For a racemic synthesis of 4, see: Ashton, M. J.; Hills, S. J.; Newton,
C. G.; Taylor, J. B.; Tondu, S. C. D. Heterocycles 1989, 28, 1015.
(12) For earlier asymmetric syntheses of 7, see: (a) Davis, F. A.;
Szewczyk, J. M. Tetrahedron Lett. 1998, 39, 5951. (b) Willoughby, C. A.;
Buchwald, S. L. J. Am. Chem. Soc. 1994, 116, 8952. (c) Deziel, R.;
Malenfant, E. J. J. Org. Chem. 1995, 60, 4660.
(13) See, for example: (a) Rubiralta, M.; Giralt, E.; Diez, A. Piperidine
Structure, Preparation, ReactiVity and Synthetic Applications of Piperidine
and its DeriVatiVes; Elsevier: Amsterdam, 1991. (b) Rubiralta, M.; Diez,
A.; Vila, C.; Troin, Y.; Feliz, M. J. Org. Chem. 1991, 56, 6292. (c) Comins,
D. L.; LaMunyon, D. H. J. Org. Chem. 1992, 57, 5807. (d) Diez, A.; Mavel,
S.; Teulade, J. C.; Chavignon, O.; Sinibaldi, M. E.; Troin, Y.; Rubiralta,
M. Heterocycles 1993, 36, 2451.
(18) For leading references to sulfinimines (N-sulfinyl imines) chemistry,
see: Davis, F. A.; Andemichael, Y. W. J. Org. Chem. 1999, 64, 8627.
1
(19) The cis alkene isomer was not detected by H NMR.
(20) Kathawala, F. G.; Prager, B.; Prasad, K.; Repic, O.; Shapiro, M. J.;
Stabler, R. S.; Widler, L. HelV. Chim. Acta 1986, 69, 803.
(21) For earlier syntheses of 14, see: (a) Ripoche, I.; Canet, J.-L.; Aboab,
B.; Gelas, J.; Troin, Y. J. Chem. Soc., Perkin Trans. 1 1998, 3485. (b)
Yokoyama, H.; Otaya, K.; Yamaguchi, S.; Hirai, Y. Tetrahedron Lett. 1998,
39, 5971. (c) Takemoto, Y.; Ueda, S.; Takeuchi, J.; Baba, Y.; Iwata, C.
Chem. Pharm. Bull. 1997, 45, 1906. (d) Takemoto, Y.; Ueda, S.; Takeuchi,
J.; Nakamoto, T.; Iwata, C. Tetrahedron Lett. 1994, 35, 8821.
(14) For leading references, see: Kudzma, L. V.; Severnak, S. A.;
Benvenga, M. J.; Ezell, E. F.; Ossipov, M. H.; Knight, V. V.; Rudo, F. G.;
Spencer, H. K.; Spaulding, T. C. J. Med. Chem. 1989, 32, 2534.
1042
Org. Lett., Vol. 2, No. 8, 2000